Join to view full profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Ingle is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1975 - 1976
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1973 - 1975- Johns Hopkins UniversityResidency, Internal Medicine, 1971 - 1973
- Johns Hopkins University School of MedicineClass of 1971
Certifications & Licensure
MN State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014
Clinical Trials
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
- Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy Start of enrollment: 1997 Dec 02
- Combination Chemotherapy in Treating Patients With Breast Cancer
Publications & Presentations
PubMed
- Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative brea...Yi Liu, Jodi M Carter, Yaohua Ma, Sachin K Deshmukh, George W Sledge Jr
Journal for Immunotherapy of Cancer. 2026-06-03 - Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal women.Jinghan Cui, Susan E Hankinson, Alvin M Matsumoto, Richard J Santen, Maegan E Boutot
The Journal of Clinical Endocrinology and Metabolism. 2026-05-12 - CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.Andrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, Annapoorna Venkatachalam, Annabella R Strathman
NPJ Breast Cancer. 2025-10-24
Journal Articles
- ERβ-Mediated Induction of Cystatins Results in Suppression of TGFβ Signaling and Inhibition of Triple-Negative Breast Cancer MetastasisMatthew P Goetz, James N Ingle, Proceedings of the National Academy of Sciences
Press Mentions
Stress Reduction for Cancer Patients – Blowing BubblesOctober 7th, 2018- Transdermal Breast Cancer TreatmentsSeptember 28th, 2018
Genotyping Errors Plague CYP2D6 Testing for Tamoxifen TherapyDecember 10th, 2014
Grant Support
- Mayo Clinic Breast Cancer SporeNational Cancer Institute2005–2011
- Developmental Research ProgramNational Cancer Institute2008–2009
- Administrative CoreNational Cancer Institute2008–2009
- Career Development ProgramNational Cancer Institute2005–2009
- C1- Administrative CoreNational Cancer Institute2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
